GSK
GlaxoSmithKline PLC
50.50$
+0.3%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -27.6% | -33.3% | +24.4% | +263.1% | +148.9% | -33.6% | +58.6% | +1.9% | +25.4% | -34.2% | +51.2% | +18.6% | +7.2% | -13.3% | -8.0% | -30.0% | +65.1% | -28.3% | -50.4% | +152.9% | +6.5% | +21.7% | -4.8% | +5.2% | -5.8% | -6.9% | +6.6% | -16.9% | +9.0% | |
| – | -9.0% | -4.0% | +19.6% | +71.7% | +10.6% | +11.8% | +17.3% | +15.1% | -10.1% | +3.2% | +17.1% | +15.8% | -17.6% | +62.9% | -19.0% | -35.3% | +30.4% | +43.2% | -8.1% | -0.1% | +60.2% | -40.9% | +69.9% | -79.2% | +304.5% | -9.0% | +24.1% | -10.5% | +44.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +10.6% | +11.1% | +45.0% | +4.1% | +10.8% | -13.3% | +4.4% | +8.1% | +1.4% | +4.4% | -3.7% | -5.7% | -11.3% | +12.1% | +8.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -13.0% | -34,232.6% | – | +2,463.4% | -23.2% | -78.9% | -43.3% | -72.4% | -8,044.8% | – | – | – | |
| – | – | – | – | – | +179.2% | -47.9% | -201.2% | – | – | – | – | – | -318.8% | – | -163.8% | – | -131.4% | – | +186.8% | -83.9% | -356.3% | – | – | -77.4% | -494.2% | – | -492.6% | – | -129.1% | |
| – | +3.5% | +14.5% | +25.7% | +84.8% | +1.3% | +9.8% | -13.4% | -76.0% | +363.1% | +34.6% | +34.8% | -3.5% | -9.5% | -12.7% | -18.8% | +14.5% | +11.9% | +2.9% | +8.6% | +23.7% | -6.4% | -18.4% | +20.4% | +3.5% | +30.9% | -23.0% | -27.7% | +82.6% | -55.8% | |
| – | +531.7% | +26.3% | +8.0% | -46.0% | +404.4% | -54.1% | -14.8% | -3.6% | +124.7% | -14.9% | +71.3% | -31.2% | +93.7% | -53.5% | -94.0% | +2,249.1% | – | -305.7% | – | -121.0% | +13.7% | +7.6% | +244.8% | – | -182.2% | +393.6% | -72.6% | -48.9% | +365.6% | |
| – | – | – | – | – | -23.2% | -0.1% | +0.3% | +6.1% | -3.4% | +8.7% | +8.1% | +7.1% | +2.8% | +3.7% | +6.3% | +12.0% | -3.5% | +4.4% | +0.8% | +25.2% | -19.5% | +0.5% | +0.7% | +0.6% | +0.6% | -13.3% | -19.4% | -12.5% | +2.6% | |
| – | – | – | – | – | – | +28.0% | -55.9% | +2.1% | 0.0% | +34.9% | +178.6% | -0.8% | -98.5% | -71.9% | +13,818.8% | +13.6% | -38.8% | -78.5% | -70.3% | -25.3% | -12.2% | – | +17.2% | -90.3% | -264.5% | – | -888.0% | – | -6,910.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +2,180.0% | -11,055.2% | – | -861.5% | – | -56.7% | -220.5% | -47.8% | +118.3% | -50.9% | -50.8% | – | |
| – | -91.0% | – | +3.2% | -256.0% | +409.4% | -22.5% | -59.5% | +290.5% | -9.5% | +35.9% | -58.4% | +97.7% | -19.5% | +100.8% | +11.9% | -46.2% | +87.2% | -14.2% | +31.9% | -10.0% | -0.2% | +0.1% | -71.2% | +450.7% | -25.1% | – | -837.4% | -22.1% | -66.3% | |
| – | -138.6% | – | – | – | -176.7% | – | – | – | +381.4% | -72.5% | +110.5% | +54.1% | -60.2% | -162.6% | – | – | – | -190.8% | – | -160.4% | – | – | +52.8% | -42.1% | -434.8% | – | – | – | -137.8% | |
| – | -55.4% | -132.5% | – | – | +366.1% | -47.5% | +106.8% | +19.1% | -2.3% | -46.3% | +54.2% | +43.5% | +13.8% | -13.5% | -4.6% | -42.0% | +93.4% | -38.0% | -80.5% | +520.5% | +13.8% | +40.5% | -11.6% | +5.9% | -19.0% | +2.5% | +21.6% | -42.9% | +63.1% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.